Overview
The purpose of this study is to evaluate the effect of a single dose of ALN-4324 on whole-body insulin sensitivity in participants with T2DM
Eligibility
Inclusion Criteria:
- Is an adult patient with a confirmed diagnosis of T2DM
- Has a body mass index (BMI) of ≥25 kg/m\^2 and \<39.9 kg/m\^2
- Has a hemoglobin A1c (HbA1c) ≥6.5% to \<10.5%
- Is on a stable dose of metformin
Exclusion Criteria:
- Has any clinically significant concomitant disease, medical condition, or abnormal laboratory finding that could compromise participant safety or confound interpretation of study results
- Receiving therapies known to interfere with glucose or insulin metabolism other than current treatment for T2DM or birth control methods
Note: other protocol defined inclusion/exclusion criteria apply


